AFA
ZBH icon

Abacus FCF Advisors’s Zimmer Biomet ZBH Stock Holding History

Abacus FCF Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-11,875
Closed -$1.72M – 181
2020
Q4 		$1.72M Sell
11,875
-1,112
-9% -$157K 1% 60
2020
Q3 		$1.87M Buy
12,987
+4,672
+56% +$610K 1% 59
2020
Q2 		$973K Buy
+8,315
New +$958K 0.92% 70

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Abacus FCF Advisors's ZBH Position: Q1 2021 in Review

Abacus FCF Advisors sold out of Zimmer Biomet (ZBH) in Q1 2021, closing a stake of 11,875 shares — an estimated $1.72M sold.

Abacus FCF Advisors first reported a position in ZBH in Q2 2020 and held it in 3 quarters. The position peaked at $1.87M in Q3 2020. 1,029 funds tracked by Wall St. Rank hold ZBH as of Q1 2021.

  • Abacus FCF Advisors reported no remaining Zimmer Biomet position as of Q1 2021 after selling out during the quarter.
  • Abacus FCF Advisors sold 11,875 Zimmer Biomet shares in Q1 2021, an estimated $1.72M.
  • Abacus FCF Advisors first reported a position in Zimmer Biomet in Q2 2020 and held it in 3 quarters.
  • Abacus FCF Advisors's Zimmer Biomet position peaked at $1.87M in Q3 2020.
  • 1,029 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2021.

Based on Abacus FCF Advisors's 13F filing for Q1 2021, filed 6 Apr 2021.